Role of sirtuins in bone biology: Potential implications for novel therapeutic strategies for osteoporosis
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The decline in bone mass and bone strength and musculoskeletal problems associated with aging constitute a major challenge for affected individuals and the healthcare system globally. Sirtuins 1‐7 (SIRT1‐SIRT7) are a family of nicotinamide adenine dinucleotide‐dependent deacetylases with remarkable abilities to promote longevity and counteract age‐related diseases. Sirtuin knockout and transgenic models have provided novel insights into the function and signaling of these proteins in bone homeostasis. Studies have revealed that sirtuins play a critical role in normal skeletal development and homeostasis through their direct action on bone cells and that their dysregulation might contribute to different bone diseases. Preclinical studies have demonstrated that mice treated with sirtuin agonists show protection against age‐related, postmenopausal, and immobilization‐induced osteoporosis. These findings suggest that sirtuins could be potential targets for the modulation of the imbalance in bone remodeling and treatment of osteoporosis and other bone disorders. The aim of this review was to provide a comprehensive updated review of the current knowledge on sirtuin biology, focusing specifically on their roles in bone homeostasis and osteoporosis, and potential pharmacological interventions targeting sirtuins for the treatment of osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690 · cited 1×
“…(IL-6), tumor necrosis factor alpha (TNF-α), and interleukin 1 (IL-1), are elevated and play direct roles in the pathogenesis of age-related diseases, including atherosclerosis, Alzheimer's disease and diabetes (Bruunsgaard, 2002; Ferrucci & Fabbri, 2018; Sarkar & Fisher, 2006; Yuan et al., 2019).”
BackgroundClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“…(long-term senolytic treatment) clearance of p16Ink4a-expressing senescent cells has been shown to extend the life span and prevent the development of multiple aging-related comorbidities in both prematurely and naturally aged mice (Baker et al., 2011; Roos et al., 2016; Xu, Palmer, et al., 2015).”
BackgroundAzevedo, R. S. S., de Sousa, J. R., Araujo, M. T. F., Martins Filho, A. J., de Alcantara, B. N., Araujo, F. M. C., Queiroz, M. G. L., Cruz, A. C. R., Vasconcelos, B. H. B., Chiang, J. O., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-17765-5 · Cited by 3,478
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 1×
“…lead to cellular senescence (LeBrasseur et al., 2015; Swanson et al., 2013; Tchkonia et al., 2013; Zhu et al., 2014), in which cells stop dividing, undergo distinct genetic and phenotypic changes, and develop a senescence-associated secretory phenotype (SASP; Blasco et al., 2013; Campisi, 2013).”
BackgroundPremature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · cited 1×
“…2 (RUNX2) through direct deacetylation of RUNX2 or indirect modulation by forming a SIRT1-forkhead box O3 (FOXO3A) complex (Shakibaei et al., 2012; Tseng et al., 2011; Zainabadi, Liu, & Guarente, 2017), and repressing peroxisome proliferator-activated receptor γ (PPARγ; Bäckesjö et al., 2006;…”
BackgroundA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“SASP is characterized by the secretion of pro-inflammatory cytokines, chemokines, and extracellular matrixdegrading proteins, which have deleterious paracrine and systemic effects (Acosta et al., 2013; Coppé et al., 2010; Nelson et al., 2012; Xu, Palmer, et al., 2015).”
BackgroundKaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085
Mitochondria: More Than Just a Powerhouse
McBride, H. M., Neuspiel, M., & Wasiak, S. (2006) · Current Biology · doi:10.1016/j.cub.2006.06.054 · Cited by 1,985 · cited 1×
“Mitochondrial dysfunction (McBride et al., 2006; Trifunovic & Larsson, 2008; Trifunovic et al., 2004; Varanasi et al., 1999), oxidative stress (Balaban et al., 2005; Cadenas & Davies, 2000), and inflammation (El Assar et al., 2013; Woods et al., 2012) are found to be closely related with the…”
BackgroundCellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774 · cited 1×
“However, resveratrol, due to its low bioavailability and potency, has demonstrated variable efficacy in humans (Tomé-Carneiro et al., 2013).”
BackgroundTherapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767 · cited 2×
“Notably, the risk of fracture doubles with every 10% of bone mass lost (Rodan & Martin, 2000).”
BackgroundNon-homologous DNA end joining and alternative pathways to double-strand break repair
Chang, H. H. Y., Pannunzio, N. R., Adachi, N., & Lieber, M. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.48 · Cited by 1,757
SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation
Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., Grueter, C. A., Harris, C., Biddinger, S., Ilkayeva, O. R., et al. (2010) · Nature · doi:10.1038/nature08778 · Cited by 1,687
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481 · cited 3×
“Mammalian sirtuins play important roles in longevity, aging-associated diseases, and response to stresses (Bonkowski & Sinclair, 2016; Donmez & Guarente, 2010; Haigis & Sinclair, 2010; Imai & Guarente, 2014; Wątroba et al., 2017).”
BackgroundInfluentialFeng, X., & McDonald, J. M. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130203 · Cited by 1,272 · cited 1×
“Finally, modulation of SIRT1 expression may prove effective for combatting Paget's disease, which is the second most common bone disorder after osteoporosis, both of which are associated with defects in bone remodeling (Feng & McDonald, 2011).”
BackgroundRegulation of autophagy by ROS: physiology and pathology
Scherz-Shouval, R., & Elazar, Z. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.07.007 · Cited by 1,263 · cited 1×
“In addition, autophagy is involved in osteoclastic bone resorption, which is regulated by ROS levels (Scherz-Shouval & Elazar, 2011; Figure 3a).”
BackgroundNAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255 · cited 1×
“In contrast, most other studies have reported increased osteoclastogenesis reported (Zhang et al., 2016a, 2018).”
ResultCantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238 · cited 1×
“In addition, NR also prevents high-fat diet-induced glucose dysregulation (Cantó et al., 2012), noise-induced hearing loss (Brown et al., 2014), cardiac injury (Xu, Barrientos, et al., 2015), and stem cell-niche depletion (Zhang, Ryu, et al., 2016).”
BackgroundMammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation
Lombard, D. B., Alt, F. W., Cheng, H.-L., Bunkenborg, J., Streeper, R. S., Mostoslavsky, R., Kim, J., Yancopoulos, G., Valenzuela, D., Murphy, A., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01636-07 · Cited by 1,216
Mouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210
Targeting cellular senescence prevents age-related bone loss in mice
Farr, J. N., Xu, M., Weivoda, M. M., Monroe, D. G., Fraser, D. G., Onken, J. L., Negley, B. A., Sfeir, J. G., Ogrodnik, M. B., Hachfeld, C. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4385 · Cited by 1,182
Haigis, M. C., Mostoslavsky, R., Haigis, K. M., Fahie, K., Christodoulou, D. C., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., Karow, M., Blander, G., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.057 · Cited by 1,162
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
Cheng, H.-L., Mostoslavsky, R., Saito, S., Manis, J. P., Gu, Y., Patel, P., Bronson, R., Appella, E., Alt, F. W., & Chua, K. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934713100 · Cited by 1,095 · cited 4×
“…2018), 7(Sun et al., 2018), 8(Park et al., 2016), 9(Zainabadi, Liu, Caldwell, et al., 2017), 10(Edwards et al., 2013), 11(Moon et al., 2019), 12(Cheng et al., 2003), 13(Lemieux et al., 2005), 14(McBurney et al., 2003), 15(Zainabadi, Liu, Guarente, 2017), 16(Jing et al., 2019), 17(Gao et al.,…”
BackgroundInfluentialThe sirtuin SIRT6 regulates lifespan in male mice
Kanfi, Y., Naiman, S., Amir, G., Peshti, V., Zinman, G., Nahum, L., Bar-Joseph, Z., & Cohen, H. Y. (2012) · Nature · doi:10.1038/nature10815 · Cited by 1,059
Mills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.013 · Cited by 930
Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds
Bonkowski, M. S., & Sinclair, D. A. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.93 · Cited by 834 · cited 3×
“NAD+ boosters serve as another class of STACs that restore NAD+ levels and potentially activate all seven sirtuins (Bonkowski & Sinclair, 2016).”
BackgroundIL-6 in autoimmune disease and chronic inflammatory proliferative disease
Ishihara, K., & Hirano, T. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00027-8 · Cited by 807
Calorie restriction–the SIR2 connection
Guarente, L., & Picard, F. (2005) · Cell · doi:10.1016/j.cell.2005.01.029 · Cited by 793 · cited 1×
“The important discovery that life span extension by caloric restriction is abolished in sirtuin-deficient yeast has inspired multiple studies on mammalian sirtuins (Guarente & Picard, 2005; Boily et al., 2008).”
BackgroundNAD+ in Brain Aging and Neurodegenerative Disorders
Lautrup, S., Sinclair, D. A., Mattson, M. P., & Fang, E. F. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.001 · Cited by 790 · cited 1×
“Therefore, future clinical studies need to be designed with good rationale to determine the dosage and administration duration for specific diseases (Gilmour et al., 2020; Lautrup et al., 2019).”
BackgroundSauve, A. A., Wolberger, C., Schramm, V. L., & Boeke, J. D. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133500 · Cited by 763
A senescent cell bystander effect: senescence‐induced senescence
Nelson, G., Wordsworth, J., Wang, C., Jurk, D., Lawless, C., Martin‐Ruiz, C., & von Zglinicki, T. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00795.x · Cited by 755
Roos, C. M., Zhang, B., Palmer, A. K., Ogrodnik, M. B., Pirtskhalava, T., Thalji, N. M., Hagler, M., Jurk, D., Smith, L. A., Casaclang‐Verzosa, G., et al. (2016) · Aging Cell · doi:10.1111/acel.12458 · Cited by 738 · cited 1×
“…(long-term senolytic treatment) clearance of p16Ink4a-expressing senescent cells has been shown to extend the life span and prevent the development of multiple aging-related comorbidities in both prematurely and naturally aged mice (Baker et al., 2011; Roos et al., 2016; Xu, Palmer, et al., 2015).”
BackgroundDefective Mitophagy in XPA via PARP-1 Hyperactivation and NAD+/SIRT1 Reduction
Fang, E. F., Scheibye-Knudsen, M., Brace, L. E., Kassahun, H., SenGupta, T., Nilsen, H., Mitchell, J. R., Croteau, D. L., & Bohr, V. A. (2014) · Cell · doi:10.1016/j.cell.2014.03.026 · Cited by 711
NAD+ homeostasis in health and disease
Katsyuba, E., Romani, M., Hofer, D., & Auwerx, J. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0161-5 · Cited by 627
Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer
Herranz, D., Muñoz-Martin, M., Cañamero, M., Mulero, F., Martinez-Pastor, B., Fernandez-Capetillo, O., & Serrano, M. (2010) · Nature Communications · doi:10.1038/ncomms1001 · Cited by 612 · cited 3×
“Encouragingly, these transgenic mice showed 40%–50% higher bone mass than that of control mice at 2.5 years of age (Herranz et al., 2010), as well as improved healthy aging.”
BackgroundMethodInfluentialThe Mammalian SIR2α Protein Has a Role in Embryogenesis and Gametogenesis
McBurney, M. W., Yang, X., Jardine, K., Hixon, M., Boekelheide, K., Webb, J. R., Lansdorp, P. M., & Lemieux, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.38-54.2003 · Cited by 611 · cited 4×
“…9(Zainabadi, Liu, Caldwell, et al., 2017), 10(Edwards et al., 2013), 11(Moon et al., 2019), 12(Cheng et al., 2003), 13(Lemieux et al., 2005), 14(McBurney et al., 2003), 15(Zainabadi, Liu, Guarente, 2017), 16(Jing et al., 2019), 17(Gao et al., 2018), 18(Huh et al., 2016), 19(Sugatani et al.,…”
BackgroundInfluentialTargeting senescent cells enhances adipogenesis and metabolic function in old age
Xu, M., Palmer, A. K., Ding, H., Weivoda, M. M., Pirtskhalava, T., White, T. A., Sepe, A., Johnson, K. O., Stout, M. B., Giorgadze, N., et al. (2015) · eLife · doi:10.7554/elife.12997 · Cited by 604
Martens, C. R., Denman, B. A., Mazzo, M. R., Armstrong, M. L., Reisdorph, N., McQueen, M. B., Chonchol, M., & Seals, D. R. (2018) · Nature Communications · doi:10.1038/s41467-018-03421-7 · Cited by 588 · cited 1×
“Although NR administration increased blood NAD+ levels and was well tolerated, it has not resulted in a striking improvement in any diseases so far (Dollerup et al., 2018; Dollerup et al., 2018; Katsyuba et al., 2020; Martens et al., 2018).”
BackgroundSirtuin activators and inhibitors: Promises, achievements, and challenges
Dai, H., Sinclair, D. A., Ellis, J. L., & Steegborn, C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.03.004 · Cited by 463 · cited 1×
“Synthetic STACs, such as SRT1720, failed to enter clinical trials due to limited target specificity (Dai et al., 2018; Huber et al., 2010; Nguyen et al., 2013).”
BackgroundSirT1 Regulates Energy Metabolism and Response to Caloric Restriction in Mice
Boily, G., Seifert, E. L., Bevilacqua, L., He, X. H., Sabourin, G., Estey, C., Moffat, C., Crawford, S., Saliba, S., Jardine, K., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001759 · Cited by 444 · cited 1×
“The important discovery that life span extension by caloric restriction is abolished in sirtuin-deficient yeast has inspired multiple studies on mammalian sirtuins (Guarente & Picard, 2005; Boily et al., 2008).”
BackgroundCoordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activation
Ishii, K.-A., Fumoto, T., Iwai, K., Takeshita, S., Ito, M., Shimohata, N., Aburatani, H., Taketani, S., Lelliott, C. J., Vidal-Puig, A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1910 · Cited by 410 · cited 1×
“…2; CTSK, cathepsin K; MMP9, matrix metalloproteinase-9; ATP, adenosine triphosphate; ADP, adenosine diphosphate; ERα, estrogen receptor alpha; FasL, fas ligand deficiency could also explain the above discrepancy due to the high energy demand of osteoclastic bone resorption (Ishii et al., 2009).”
BackgroundBellizzi, D., Rose, G., Cavalcante, P., Covello, G., Dato, S., De Rango, F., Greco, V., Maggiolini, M., Feraco, E., Mari, V., et al. (2005) · Genomics · doi:10.1016/j.ygeno.2004.11.003 · Cited by 367
SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair
McCord, R. A., Michishita, E., Hong, T., Berber, E., Boxer, L. D., Kusumoto, R., Guan, S., Shi, X., Gozani, O., Burlingame, A. L., et al. (2009) · Aging · doi:10.18632/aging.100011 · Cited by 313
SIRT6 protects against pathological damage caused by diet‐induced obesity
Kanfi, Y., Peshti, V., Gil, R., Naiman, S., Nahum, L., Levin, E., Kronfeld‐Schor, N., & Cohen, H. Y. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2009.00544.x · Cited by 311
SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease
Shin, J., He, M., Liu, Y., Paredes, S., Villanova, L., Brown, K., Qiu, X., Nabavi, N., Mohrin, M., Wojnoonski, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.007 · Cited by 287
Rose, G., Dato, S., Altomare, K., Bellizzi, D., Garasto, S., Greco, V, Passarino, G., Feraco, E., Mari, V, Barbi, C., et al. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00209-2 · Cited by 282 · cited 1×
“SIRT3, a mitochondrial NAD+-dependent protein deacetylase (Ansari et al., 2017; Lombard et al., 2007), was found to be associated with long life span in humans and has, thus, attracted public and research interest (Bellizzi et al., 2005; Rose et al., 2003).”
BackgroundDollerup, O. L., Christensen, B., Svart, M., Schmidt, M. S., Sulek, K., Ringgaard, S., Stødkilde-Jørgensen, H., Møller, N., Brenner, C., Treebak, J. T., et al. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy132 · Cited by 282 · cited 1×
“Although NR administration increased blood NAD+ levels and was well tolerated, it has not resulted in a striking improvement in any diseases so far (Dollerup et al., 2018; Dollerup et al., 2018; Katsyuba et al., 2020; Martens et al., 2018).”
BackgroundBrown, K. D., Maqsood, S., Huang, J.-Y., Pan, Y., Harkcom, W., Li, W., Sauve, A., Verdin, E., & Jaffrey, S. R. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.11.003 · Cited by 277
Cellular senescence and the senescent secretory phenotype in age-related chronic diseases
Zhu, Y., Armstrong, J. L., Tchkonia, T., & Kirkland, J. L. (2014) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000065 · Cited by 273 · cited 1×
“…reactive metabolites, and proteotoxic stress, lead to cellular senescence (LeBrasseur et al., 2015; Swanson et al., 2013; Tchkonia et al., 2013; Zhu et al., 2014), in which cells stop dividing, undergo distinct genetic and phenotypic changes, and develop a senescence-associated secretory…”
BackgroundSwanson, E. C., Manning, B., Zhang, H., & Lawrence, J. B. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201306073 · Cited by 251 · cited 1×
“These findings were consistent with reduced levels of SIRT1 measured in human osteoarthritis (OA) cartilage (Fujita et al., 2011; Takayama et al., 2009), suggesting a potential protective role of SIRT1 in chondrocytes, which was further evidenced by the accelerated development of OA in mice lacking…”
SIRT3 regulates progression and development of diseases of aging
McDonnell, E., Peterson, B. S., Bomze, H. M., & Hirschey, M. D. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.06.001 · Cited by 217 · cited 1×
“However, aging-related health problems such as metabolic syndrome, cancer, and cardiovascular and neurodegenerative diseases were observed earlier in the SIRT3 KO mice (McDonnell et al., 2015; Van de Ven et al., 2017).”
BackgroundDNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age
Kim, H., Chang, J., Shao, L., Han, L., Iyer, S., Manolagas, S. C., O'Brien, C. A., Jilka, R. L., Zhou, D., & Almeida, M. (2017) · Aging Cell · doi:10.1111/acel.12597 · Cited by 192
Irie, J., Inagaki, E., Fujita, M., Nakaya, H., Mitsuishi, M., Yamaguchi, S., Yamashita, K., Shigaki, S., Ono, T., Yukioka, H., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej19-0313 · Cited by 191
Cellular Senescence and the Biology of Aging, Disease, and Frailty
LeBrasseur, N. K., Tchkonia, T., & Kirkland, J. L. (2015) · Nestlé Nutrition Institute Workshop Series · doi:10.1159/000382054 · Cited by 147
Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
Stegen, S., Stockmans, I., Moermans, K., Thienpont, B., Maxwell, P. H., Carmeliet, P., & Carmeliet, G. (2018) · Nature Communications · doi:10.1038/s41467-018-04679-7 · Cited by 126
Treiber, N., Maity, P., Singh, K., Kohn, M., Keist, A. F., Ferchiu, F., Sante, L., Frese, S., Bloch, W., Kreppel, F., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00658.x · Cited by 109
Wang, H., Chen, Q., Lee, S., Choi, Y., Brad Johnson, F., & Pignolo, R. J. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00838.x · Cited by 81 · cited 2×
“In addition to the KO models, SIRT1 overexpression mouse models have also been developed to study the impact of SIRT1 activation on bone homeostasis (Herranz et al., 2010; Sun et al., 2018; Wang et al., 2019).”
BackgroundYun, A. J., & Lee, P. Y. (2004) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00326-8 · Cited by 76 · cited 1×
“…and activation, which has been linked to accelerated bone loss in various bone disorders including postmenopausal osteoporosis, Paget's disease, and idiopathic osteoporosis (Kim et al., 2009; Manolagas & Jilka, 1995; Moffett et al., 2005; Pacifici et al., 1989; Wei et al., 2005; Yun & Lee, 2004).”
BackgroundSIRT2 deficiency prevents age-related bone loss in rats by inhibiting osteoclastogenesis
Jing, Y., Zhou, Y., Zhou, F., Wang, X., Tao, B., Sun, L., Liu, J., & Zhao, H. (2019) · Cellular and Molecular Biology · doi:10.14715/cmb/2019.65.7.12 · Cited by 22 · cited 4×
“…2013), 11(Moon et al., 2019), 12(Cheng et al., 2003), 13(Lemieux et al., 2005), 14(McBurney et al., 2003), 15(Zainabadi, Liu, Guarente, 2017), 16(Jing et al., 2019), 17(Gao et al., 2018), 18(Huh et al., 2016), 19(Sugatani et al., 2015), 20(Zhang, Ryu, et al., 2016), 21(Zhang et al., 2018),…”
BackgroundInfluential
Cited by
Novel Role of the SIRT1 in Endocrine and Metabolic Diseases
Lu, C., Zhao, H., Liu, Y., Yang, Z., Yao, H., Liu, T., Gou, T., Wang, L., Zhang, J., Tian, Y., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.78654 · Cited by 160
“Menopausal, ovariectomized female mice and aged male mice exhibit decreased SIRT1, osteoporosis and bone injury [135].”
Fekete, M., Szarvas, Z., Fazekas-Pongor, V., Feher, A., Csipo, T., Forrai, J., Dosa, N., Peterfi, A., Lehoczki, A., Tarantini, S., et al. (2022) · Nutrients · doi:10.3390/nu15010047 · Cited by 137
Gan, D., Qin, L., & Xiao, G. (2026) · Research · doi:10.34133/research.1319 · Cited by 1
“…support”) Lower hepatic lipid toxicity, enhance osteoblast activity [177] • Sirtuins in bone cells Promote bone growth and remodeling balance [178] • Vitamin D and calcium supplementation Offset malabsorption, improve mineralization [179] • Antiviral therapy for hepatitis Restores liver…”
Metadata
- Authors
- Li, Q., Cheng, J. C., Jiang, Q., & Lee, W. Y.
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2021-01-04
- Volume
- 20
- Issue
- 2
- Pages
- e13301-e13301
- ISSN
- 1474-9718 (ISSN-L)
- 1474-9726
- OpenAlex
- W3119018627
- Cited by
- 58
- References
- 60
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.